Immune checkpoint inhibitor therapy-induced autoimmune polyendocrine syndrome type II and Crohn’s disease: A case report

Figure 1 Temporal changes in laboratory parameters during treatment and follow-up. A: Blood glucose; B: Amylase; C: Serum creatinine; D: Serum sodium; E: C-reactive protein; F: Creatine kinase.

Figure 2 Colonoscopy and abdominal computed tomography examination. A: Electronic colonoscopy image; B: Abdominal computed tomography scan.

Figure 3 Hematoxylin and eosin-stained sections of terminal ileum. A: 5 times amplification by microscope of the lesions in intestine; B: 50 times amplification by microscope of the lesions in intestine; C: 100 times amplification by microscope of the lesions in intestine; D: 200 times amplification by microscope of the lesions in intestine.